{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:41:33Z","timestamp":1784241693787,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T00:00:00Z","timestamp":1353974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Legal Med"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00414-012-0796-1","type":"journal-article","created":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T13:11:05Z","timestamp":1353935465000},"page":"593-601","source":"Crossref","is-referenced-by-count":54,"title":["Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS\/MS"],"prefix":"10.1007","volume":"127","author":[{"given":"Rafaela","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Sch\u00fcrenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"796_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-2952(61)90124-1","volume":"7","author":"A Horita","year":"1961","unstructured":"Horita A, Weber LJ (1961) The enzymic dephosphorylation and oxidation of psilocybin and pscilocin by mammalian tissue homogenates. Biochem Pharmacol 7:47\u201354","journal-title":"Biochem Pharmacol"},{"key":"796_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0031-6865(97)00014-9","volume":"72","author":"F Hasler","year":"1997","unstructured":"Hasler F, Bourquin D, Brenneisen R, B\u00e4r T, Vollenweider FX (1997) Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharm Acta Helv 72:175\u2013184","journal-title":"Pharm Acta Helv"},{"key":"796_CR3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hlca.19590420518","volume":"42","author":"A Hofmann","year":"1959","unstructured":"Hofmann A, Heim R, Brack A, Kobel H, Frey A, Ott H, Petrzilka T, Troxler F (1959) Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen. Helv Chim Acta 42:1557\u20131572","journal-title":"Helv Chim Acta"},{"key":"796_CR4","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-09677-2","volume-title":"Rauschdrogen, Marktformen und Wirkungsweisen","author":"T Geschwinde","year":"2003","unstructured":"Geschwinde T (2003) Rauschdrogen, Marktformen und Wirkungsweisen. Springer, Berlin"},{"key":"796_CR5","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2006) EMCDDA Thematic Papers\u2014Hallucinogenic mushrooms: an emerging trend case study. http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_31215_EN_TP_Hallucinogenic_mushrooms.pdf . Accessed 13 Jul 2011"},{"key":"796_CR6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1520\/JFS15014J","volume":"46","author":"AF Grieshaber","year":"2001","unstructured":"Grieshaber AF, Moore KA, Levine B (2001) The detection of psilocin in human urine. J Forensic Sci 46:627\u2013630","journal-title":"J Forensic Sci"},{"key":"796_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jchromb.2003.08.030","volume":"796","author":"T Kamata","year":"2003","unstructured":"Kamata T, Nishikawa M, Katagi M, Tsuchihashi H (2003) Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples. J Chromatogr B 796:421\u2013427","journal-title":"J Chromatogr B"},{"key":"796_CR8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11419-006-0006-2","volume":"24","author":"T Kamata","year":"2006","unstructured":"Kamata T, Nishikawa M, Katagi M, Tsuchihashi H (2006) Direct detection of serum psilocin glucuronide by LC\/MS and LC\/MS\/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a \u201cmagic mushroom\u201d user. Forensic Toxicol 24:36\u201340","journal-title":"Forensic Toxicol"},{"key":"796_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-1781(95)02747-K","volume":"58","author":"J K\u00e4rkk\u00e4inen","year":"1995","unstructured":"K\u00e4rkk\u00e4inen J, R\u00e4is\u00e4nen M, Huttunen MO, Kallio E, Naukkarinen H, Virkkunen M (1995) Urinary excretion of bufotenin (N,N-dimethyl-5-hydroxytryptamine) is increased in suspicious violent offenders: a confirmatory study. Psychiatry Res 58:145\u2013152","journal-title":"Psychiatry Res"},{"key":"796_CR10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/02791072.1996.10472488","volume":"28","author":"T Lyttle","year":"1996","unstructured":"Lyttle T, Goldstein D, Gartz J (1996) Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic. J Psychoactive Drugs 28:267\u2013290","journal-title":"J Psychoactive Drugs"},{"key":"796_CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchromb.2004.12.040","volume":"825","author":"SS Johansen","year":"2005","unstructured":"Johansen SS, Jensen JL (2005) Liquid chromatography-tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case. J Chromatogr B 825:21\u201328","journal-title":"J Chromatogr B"},{"key":"796_CR12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-4347(99)00189-9","volume":"733","author":"SA Reuschel","year":"1999","unstructured":"Reuschel SA, Eades D, Foltz RL (1999) Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens. J Chromatogr B 733:145\u2013159","journal-title":"J Chromatogr B"},{"key":"796_CR13","unstructured":"Holzmann P (1995) Bestimmung von Psilocybin-Metaboliten im Humanplasma und -urin. Dissertation, Eberhard-Karls-Universit\u00e4t"},{"key":"796_CR14","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/clinchem\/48.9.1615","volume":"48","author":"G Skopp","year":"2002","unstructured":"Skopp G, P\u00f6tsch L, Mattern R, Aderjan R (2002) Short-term stability of lysergic acid diethylamide (LSD), N-desmethyl-LSD, and 2-oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography-tandem mass spectrometry. Clin Chem 48:1615\u20131618","journal-title":"Clin Chem"},{"key":"796_CR15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jat\/14.3.189","volume":"14","author":"DI Papac","year":"1990","unstructured":"Papac DI, Foltz RL (1990) Measurement of lysergic acid diethylamide (LSD) in human plasma by gas chromatography\/negative ion chemical ionization mass spectrometry. J Anal Toxicol 14:189\u2013190","journal-title":"J Anal Toxicol"},{"key":"796_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.aca.2004.08.071","volume":"527","author":"K Saito","year":"2004","unstructured":"Saito K, Toyo\u2019oka T, Fukushima T, Kato M, Shirota O, Goda Y (2004) Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometry. Anal Chim Acta 527:149\u2013156","journal-title":"Anal Chim Acta"},{"key":"796_CR17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jchromb.2009.03.004","volume":"877","author":"K Bj\u00f6rnstad","year":"2009","unstructured":"Bj\u00f6rnstad K, Beck O, Helander A (2009) A multi-component LC-MS\/MS method for detection of ten plant-derived psychoactive substances in urine. J Chromatogr B 877:1162\u20131168","journal-title":"J Chromatogr B"},{"key":"796_CR18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0379-0738(00)00213-9","volume":"113","author":"G Sticht","year":"2000","unstructured":"Sticht G, K\u00e4ferstein H (2000) Detection of psilocin in body fluids. Forensic Sci Int 113:403\u2013407","journal-title":"Forensic Sci Int"},{"key":"796_CR19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-4347(00)00461-8","volume":"748","author":"MJ Bogusz","year":"2000","unstructured":"Bogusz MJ (2000) Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity. J Chromatogr B 748:3\u201319","journal-title":"J Chromatogr B"},{"key":"796_CR20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jat\/31.8.497","volume":"31","author":"M Mar Ramirez Fernandez del","year":"2007","unstructured":"del Mar Ramirez Fernandez M, Laloup M, Wood M, De Boeck G, Lopez-Rivadulla M, Wallemacq P, Samyn N (2007) Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine. J Anal Toxicol 31:497\u2013504","journal-title":"J Anal Toxicol"},{"key":"796_CR21","first-page":"854","volume":"29","author":"AA Elian","year":"2011","unstructured":"Elian AA, Hackett J, Telepchak MJ (2011) Analysis of psilocybin and psilocin in urine using SPE and LC-tandem mass spectrometry. LC-GC North America 29:854\u2013859","journal-title":"LC-GC North America"},{"key":"796_CR22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jat\/24.7.543","volume":"24","author":"JH Sklerov","year":"2000","unstructured":"Sklerov JH, Magluilo J, Shannon KK, Smith ML (2000) Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood. J Anal Toxicol 24:543\u2013549","journal-title":"J Anal Toxicol"},{"key":"796_CR23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00007691-200108000-00011","volume":"23","author":"K Bodin","year":"2001","unstructured":"Bodin K, Svensson J (2001) Determination of LSD in urine with high-performance liquid chromatography-mass spectrometry. Ther Drug Monit 23:389\u2013393","journal-title":"Ther Drug Monit"},{"key":"796_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-4347(01)00386-3","volume":"765","author":"J Canezin","year":"2001","unstructured":"Canezin J, Cailleux A, Turcant A, Le Bouil A, Harry P, Allain P (2001) Determination of LSD and its metabolites in human biological fluids by high-performance liquid chromatography with electrospray tandem mass spectrometry. J Chromatogr B 765:15\u201327","journal-title":"J Chromatogr B"},{"key":"796_CR25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00414-006-0078-x","volume":"121","author":"D Favretto","year":"2007","unstructured":"Favretto D, Frison G, Maietti S, Ferrara S (2007) LC-ESI-MS\/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor. Int J Legal Med 121:259\u2013265","journal-title":"Int J Legal Med"},{"key":"796_CR26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jat\/33.5.253","volume":"33","author":"A Chung","year":"2009","unstructured":"Chung A, Hudson J, McKay G (2009) Validated ultra-performance liquid chromatography-tandem mass spectrometry method for analyzing LSD, iso-LSD, nor-LSD, and O-H-LSD in blood and urine. J Anal Toxicol 33:253\u2013259","journal-title":"J Anal Toxicol"},{"key":"796_CR27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jat\/27.7.459","volume":"27","author":"CK Horn","year":"2003","unstructured":"Horn CK, Klette KL, Stout PR (2003) LC-MS analysis of 2-oxo-3-hydroxy LSD from urine using a Speedisk positive-pressure processor with Cerex(r) PolyChrom(tm) CLIN II Columns. J Anal Toxicol 27:459\u2013463","journal-title":"J Anal Toxicol"},{"key":"796_CR28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jat\/31.9.573","volume":"31","author":"M Concheiro","year":"2007","unstructured":"Concheiro M, De Castro A, Quintela O, Cruz A, L\u00f3pez-Rivadulla M (2007) Determination of illicit drugs and their metabolites in human urine by liquid chromatography tandem mass spectrometry including relative ion intensity criterion. J Anal Toxicol 31:573\u2013580","journal-title":"J Anal Toxicol"},{"key":"796_CR29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/003655101753218319","volume":"61","author":"J Forsstr\u00f6m","year":"2001","unstructured":"Forsstr\u00f6m J, Tuominen J, K\u00e4rkk\u00e4inen T (2001) Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC\/ESI-MS-MS. Scand J Clin Lab Invest 61:547\u2013556","journal-title":"Scand J Clin Lab Invest"},{"key":"796_CR30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/00365510510013604","volume":"65","author":"J K\u00e4rkk\u00e4inen","year":"2005","unstructured":"K\u00e4rkk\u00e4inen J, Forsstr\u00f6m T, Tornaeus J, W\u00e4h\u00e4l\u00e4 K, Kiuru P, Honkanen A, Stenman U, Turpeinen U, Hesso A (2005) Potentially hallucinogenic 5\u2013hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues. Scand J Clin Lab Invest 65:189\u2013199","journal-title":"Scand J Clin Lab Invest"},{"key":"796_CR31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2009.02.006","volume":"188","author":"C Kostakis","year":"2009","unstructured":"Kostakis C, Byard RW (2009) Sudden death associated with intravenous injection of toad extract. Forensic Sci Int 188:e1\u2013e5","journal-title":"Forensic Sci Int"},{"key":"796_CR32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0022-3565(25)31309-1","volume":"206","author":"LJ Riceberg","year":"1978","unstructured":"Riceberg LJ, Vunakis HV (1978) Determination of N,N-dimethylindolealkylamines in plasma, blood and urine extracts by radioimmunoassay and high pressure liquid chromatography. J Pharmacol Exp Ther 206:158\u2013166","journal-title":"J Pharmacol Exp Ther"},{"key":"796_CR33","first-page":"185","volume":"76","author":"F Peters","year":"2009","unstructured":"Peters F, Hartung M, Herbold M, Schmitt G, Daldrup T, Mu\u00dfhoff F (2009) Anhang B zur Richtlinie der GTFCh zur Qualit\u00e4tssicherung bei forensisch-toxikologischen Untersuchungen: Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech 76:185\u2013208","journal-title":"Toxichem Krimtech"},{"key":"796_CR34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00414-011-0652-8","volume":"126","author":"R Martin","year":"2012","unstructured":"Martin R, Sch\u00fcrenkamp J, Pfeiffer H, K\u00f6hler H (2012) A validated method for quantitation of psilocin in plasma by LC-MS\/MS and study of stability. Int J Legal Med 126:845\u2013849","journal-title":"Int J Legal Med"},{"key":"796_CR35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0731-7085(02)00278-9","volume":"30","author":"F Hasler","year":"2002","unstructured":"Hasler F, Bourquin D, Brenneisen R, Vollenweider FX (2002) Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. J Pharm Biomed Anal 30:331\u2013339","journal-title":"J Pharm Biomed Anal"},{"key":"796_CR36","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/0024-3205(84)90368-0","volume":"34","author":"MJ R\u00e4is\u00e4nen","year":"1984","unstructured":"R\u00e4is\u00e4nen MJ (1984) The presence of free and conjugated bufotenin in normal human urine. Life Sci 34:2041\u20132045","journal-title":"Life Sci"}],"container-title":["International Journal of Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-012-0796-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00414-012-0796-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-012-0796-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T20:47:57Z","timestamp":1745354877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00414-012-0796-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,27]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1007\/s00414-012-0796-1","relation":{},"ISSN":["0937-9827","1437-1596"],"issn-type":[{"value":"0937-9827","type":"print"},{"value":"1437-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,27]]}}}